PeterYoung JaeYuMD

PubMed

• 2 citations
  Resection Status Does Not Impact Recurrence in Well-Differentiated Liposarcoma of the Extremity.
  , , , , , , , , , , , , , , , , , , , > ;The American Surgeon. 2021 Nov 10
• 15 citations
  β-catenin S45F mutation results in apoptotic resistance
  Danielle Braggio, Priya Londhe, Peter Y. Yu, Gonzalo Lopez, Kara Batte, David Koller, Fernanda Costas Casal de Faria, Lucia Casadei, Anne M. Strohecker, Dina Lev, Raph...> ;Oncogene. 2020 Jul 10
• 5 citations
  Neoadjuvant radiation improves margin-negative resection rates in extremity sarcoma but not survival.
  Rita D. Shelby, Lorena P. Suarez-Kelly, Peter Y. Yu, Tasha M. Hughes, Cecilia G. Ethun, Thuy B. Tran, George A. Poultsides, David M. King, Meena Bedi, Harveshp Mogal, ...> ;Journal of Surgical Oncology. 2020 Mar 30
• 2 citations
  Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas.
  Malcolm H. Squires, Cecilia G. Ethun, Lorena P. Suarez-Kelly, Peter Y. Yu, Tasha M. Hughes, Rita D. Shelby, Thuy B. Tran, George A. Poultsides, John A. Charlson, T. Cl...> ;The Journal of Surgical Research. 2020 Jan 1
• 3 citations
  Perioperative chemotherapy is not associated with improved survival in high-grade truncal sarcoma.
  Peter Y. Yu, Eliza W. Beal, Tasha M. Hughes, Lorena P. Suarez-Kelly, Rita D. Shelby, Cecilia G. Ethun, Thuy B. Tran, George A. Poultsides, John A. Charlson, T. Clark G...> ;The Journal of Surgical Research. 2018 Jun 23
• 11 citations
  miR-133a function in the pathogenesis of dedifferentiated liposarcoma
  Peter Y. Yu, Gonzalo Lopez, Danielle Braggio, David Koller, Kate Lynn J. Bill, Bethany C. Prudner, James L. Chen, O. Hans Iwenofu, Dina Lev, Anne M. Strohecker, Joelle...> ;Cancer Cell International. 2018 Jun 26
• 46 citations
  Classical NF-κB Metabolically Reprograms Sarcoma Cells Through Regulation of Hexokinase 2.
  Priya Londhe, Peter Y. Yu, Yuichi Ijiri, Katherine J. Ladner, Joelle M. Fenger, Cheryl A. London, Peter J. Houghton, Denis C. Guttridge> ;Frontiers in Oncology. 2018 Apr 11
• 9 citations
  Dysregulated Myogenesis in Rhabdomyosarcoma.
  Peter Y. Yu, Denis C. Guttridge> ;Current Topics in Developmental Biology. 2018 Jan 1
• 26 citations
  MiR-34a regulates the invasive capacity of canine osteosarcoma cell lines
  Cecilia M. Lopez, Peter Y. Yu, Xiaoli Zhang, Ayse Selen Yilmaz, Cheryl A. London, Joelle M. Fenger> ;Plos One. 2018 Jan 2
• 9 citations
  Mocetinostat combined with gemcitabine for the treatment of leiomyosarcoma: Preclinical correlates.
  Gonzalo Lopez, Danielle Braggio, Lucia Casadei, Kara Batte, Hemant Kumar Bid, David Koller, Peter Y. Yu, Obiajulu H. Iwenofu, Anne M. Strohecker, Edwin Choy, Dina Lev,...> ;Plos One. 2017 Nov 29
• 14 citations
  Target specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma.
  Peter Y. Yu, Heather L. Gardner, Ryan D. Roberts, Hakan Cam, Seethalakshmi Hariharan, Ling Ren, Amy K. LeBlanc, Hui Xiao, Jiayuh Lin, Denis C. Guttridge, Xiaokui Mo, C...> ;Plos One. 2017 Jul 27
• 7 citations
  A selective screening platform reveals unique global expression patterns of microRNAs in a cohort of human soft-tissue sarcomas
  Peter Y. Yu, Mumtaz Yaseen Balkhi, Katherine J. Ladner, Hansjuerg Alder, Lianbo Yu, Xiaokui Mo, William G. Kraybill, Denis C. Guttridge, O. Hans Iwenofu> ;Laboratory Investigation; a Journal of Technical Methods and Pathology. 2016 Feb 15
• Join now to see all